# Fipamezole in Neurogenic Orthostatic Hypotension

> **NCT00758849** · PHASE2 · UNKNOWN · sponsor: **Juvantia Pharma Ltd** · enrollment: 24 (estimated)

## Conditions studied

- Symptomatic Neurogenic Orthostatic Hypotension (NOH)
- Parkinson's Disease
- Multiple System Atrophy

## Interventions

- **DRUG:** Placebo
- **DRUG:** Fipamezole

## Key facts

- **NCT ID:** NCT00758849
- **Lead sponsor:** Juvantia Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2008-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00758849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00758849, "Fipamezole in Neurogenic Orthostatic Hypotension". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00758849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*